Continuous Glucose Monitoring

Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • Rep Id : TMRGL1169
  • Published On : Mar 2014
  • No. of Pages : 68
  • Category : Healthcare

 
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
               1.3.1.1 Secondary Research
               1.3.1.2 Primary Research
      1.3.2 Assumptions
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Continuous Glucose Monitoring Market (2012 & 2019)
2.2 Global Continuous Glucose Monitoring Market, by Device/Brand, 2012 (USD Million)
 
Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
      3.2.1 Rise in diabetic population globally
      3.2.2 Rise in demand for point of care testing (POCT)
3.3 Market Restraints
      3.3.1 Unfavourable reimbursement policies
      3.3.2 Calibration issues
3.4 Market Opportunities
      3.4.1 Development of continuous glucose monitoring devices based on non-invasive techniques
3.5 Porter’s Five Forces Analysis for the Global Continuous Glucose Monitoring Market
      3.5.1 Bargaining power of suppliers
      3.5.2 Bargaining power of buyers
      3.5.3 Threat of substitutes
      3.5.4 Threat of new entrants
      3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Continuous Glucose Monitoring Market, by Geography
 
Chapter 4 Continuous Glucose Monitoring (CGM) Market, by Device/Brand, 2011 – 2019 (USD Million)
4.1 Overview
      4.1.1 Global Continuous Glucose Monitoring Market, by Device/Brand, 2011 – 2019 (USD Million)
4.2 Guardian Real Time CGM System
      4.2.1 Global Guardian Real Time CGM System Market, 2011 – 2019 (USD Million)
4.3 FreeStyle Navigator
      4.3.1 Global FreeStyle Navigator Market, 2011 – 2019 (USD Million)
4.4 Dexcom Seven Plus CGM System
      4.4.1 Global Dexcom Seven Plus CGM System Market, 2011 – 2019 (USD Million)
4.5 Dexcom G4 Platinum
      4.5.1 Global Dexcom G4 Platinum Market, 2011 – 2019 (USD Million)
4.6 MiniMed Paradigm Revel/Veo System
      4.6.1 Global MiniMed Paradigm Revel/Veo System Market, 2011 – 2019 (USD Million)
4.7 Others
      4.7.1 Global Other CGM Systems Market, 2011 – 2019 (USD Million)
 
Chapter 5 Global Continuous Glucose Monitoring  Market Revenue, by Geography, 2011 - 2019 (USD Million)
5.1 Overview
      5.1.1 Global Continuous Glucose Monitoring  Market Revenue, by Geography, 2011 - 2019 (USD Million)
      5.1.2 Comparative Analysis: Global Continuous Glucose Monitoring Market Revenue, by Geography, 2012 & 2019 (Value %)
5.2 North America
      5.2.1 North America Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
5.3 Europe
      5.3.1 Europe Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
5.4 Asia-Pacific
      5.4.1 Asia-Pacific Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
5.5 Rest of the World (RoW)
      5.5.1 Rest of the World (RoW) Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
 
Chapter 6 Competitive Landscape
6.1 Market Share Analysis by Key Players: Global Continuous Glucose Monitoring Market
      6.1.1 Global Continuous Glucose Monitoring Market Share Analysis, by Key Players, 2012 (%)
 
Chapter 7 Recommendations
7.1 Focus on emerging economies of Asia-Pacific, Latin America, Middle East and Africa
7.2 Investing in research and development of technologically advanced products with added benefits
7.3 Emphasis on price control
 
Chapter 8 Company Profiles
8.1 Abbott Laboratories
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Bayer AG
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 Dexcom, Inc.
      8.3.1 Company overview
      8.3.2 Financial overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 GlySens Incorporated
      8.4.1 Company overview
      8.4.2 Product Portfolio
      8.4.3 Business Strategies
8.5 Insulet Corporation
      8.5.1 Company overview
      8.5.2 Financial overview
      8.5.3 Product portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Developments
8.6 Medtronic, Inc.
      8.6.1 Business Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
      8.6.5 Recent Development
8.7 Nova Biomedical Corporation
      8.7.1 Company overview
      8.7.2 Product portfolio
      8.7.3 Business Strategies
      8.7.4 Recent Developments
8.8 Senseonics, Incorporated
      8.8.1 Company overview
      8.8.2 Product portfolio
      8.8.3 Business Strategies
      8.8.4 Recent Developments

List of Tables
 
TABLE 1 Market Snapshot: Global Continuous Glucose Monitoring Market (2012 & 2019)
TABLE 2 Number of People with Diabetes (20-79 years), by Country/Territory, 2013 (Millions)
TABLE 3 Global Continuous Glucose Monitoring Market, by Device/Brand, 2011 – 2019 (USD Million)
TABLE 4 Global Continuous Glucose Monitoring  Market Revenue, by Geography, 2011 – 2019 (USD Million)

List of Figures
 
FIG. 1 Continuous Glucose Monitoring: Market Segmentation
FIG. 2 Global Continuous Glucose Monitoring Market, by Device/Brand, 2012 (USD Million)
FIG. 3 Porter’s Five Force Analysis: Global Continuous Glucose Monitoring Market
FIG. 4 Market Attractiveness Analysis: Global Continuous Glucose Monitoring Market, by Geography
FIG. 5 Global Guardian Real Time CGM System Market, 2011 – 2019 (USD Million)
FIG. 6 Global FreeStyle Navigator Market, 2011 – 2019 (USD Million)
FIG. 7 Global Dexcom Seven Plus CGM System Market, 2011 – 2019 (USD Million)
FIG. 8 Global Dexcom G4 Platinum Market, 2011 – 2019 (USD Million)
FIG. 9 Global MiniMed Paradigm Revel/Veo System Market, 2011 – 2019 (USD Million)
FIG. 10 Global Other CGM Systems Market, 2011 – 2019 (USD Million)
FIG. 11 Comparative Analysis: Global Continuous Glucose Monitoring Market Revenue, by Geography, 2012 & 2019 (Value %)
FIG. 12 North America Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Europe Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Asia-Pacific Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 RoW Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Continuous Glucose Monitoring Market Share Analysis, by Key Players, 2012 (%)
FIG. 17 Annual Revenue: Abbott Laboratories, Inc., 2010 – 2012 (USD Million)
FIG. 18 Annual Revenue: Bayer AG., 2010 – 2012 (USD Million)
FIG. 19 Annual Revenue: Dexcom, Inc., 2010 – 2012 (USD Million)
FIG. 20 Annual Revenue: Insulet Corporation, 2010 – 2012 (USD Million)
FIG. 21 Annual Revenue: Medtronic, Inc., 2010 – 2012 (USD Million)